$5.06 Billion is the total value of Rock Springs Capital Management LP's 156 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 15.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGL | New | AGILON HEALTH INC | $283,950,000 | – | 6,999,023 | +100.0% | 5.61% | – |
| ZLAB | Buy | ZAI LAB LTDadr | $179,468,000 | +44.1% | 1,014,000 | +8.6% | 3.55% | +30.5% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $141,870,000 | +8.0% | 2,574,308 | +1.2% | 2.80% | -2.2% |
| HUM | Buy | HUMANA INC | $133,923,000 | +6.1% | 302,500 | +0.5% | 2.65% | -3.9% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $114,715,000 | +19.3% | 187,750 | +5.8% | 2.27% | +8.1% |
| IDXX | IDEXX LABS INC | $113,679,000 | +29.1% | 180,000 | 0.0% | 2.25% | +17.0% | |
| PODD | Buy | INSULET CORP | $112,206,000 | +15.9% | 408,750 | +10.2% | 2.22% | +5.0% |
| ISRG | INTUITIVE SURGICAL INC | $110,357,000 | +24.5% | 120,000 | 0.0% | 2.18% | +12.7% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $98,780,000 | +0.1% | 1,015,000 | 0.0% | 1.95% | -9.3% | |
| NVAX | Sell | NOVAVAX INC | $96,601,000 | +15.6% | 455,000 | -1.3% | 1.91% | +4.7% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $96,106,000 | -6.1% | 240,000 | -12.7% | 1.90% | -14.9% |
| ARGX | Buy | ARGENX SEsponsored adr | $94,837,000 | +14.8% | 315,000 | +5.0% | 1.87% | +4.0% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $93,517,000 | -4.2% | 2,394,785 | +4.5% | 1.85% | -13.2% |
| HCA | HCA HEALTHCARE INC | $93,033,000 | +9.8% | 450,000 | 0.0% | 1.84% | -0.5% | |
| NVRO | Buy | NEVRO CORP | $88,034,000 | +30.1% | 531,000 | +9.5% | 1.74% | +17.9% |
| FRPT | FRESHPET INC | $82,539,000 | +2.6% | 506,500 | 0.0% | 1.63% | -7.1% | |
| NVTA | Buy | INVITAE CORP | $77,648,000 | -8.2% | 2,302,032 | +4.0% | 1.54% | -16.8% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $71,147,000 | -2.0% | 808,860 | +8.3% | 1.41% | -11.2% |
| EXAS | EXACT SCIENCES CORP | $70,857,000 | -5.7% | 570,000 | 0.0% | 1.40% | -14.6% | |
| BGNE | BEIGENE LTDsponsored adr | $68,638,000 | -1.4% | 200,000 | 0.0% | 1.36% | -10.7% | |
| GRPH | New | GRAPHITE BIO INC | $66,123,000 | – | 2,151,738 | +100.0% | 1.31% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $66,066,000 | -26.5% | 3,762,312 | +5.4% | 1.31% | -33.4% |
| PCRX | PACIRA BIOSCIENCES INC | $62,197,000 | -13.4% | 1,025,000 | 0.0% | 1.23% | -21.6% | |
| EW | EDWARDS LIFESCIENCES CORP | $60,278,000 | +23.8% | 582,000 | 0.0% | 1.19% | +12.1% | |
| PHR | Buy | PHREESIA INC | $58,848,000 | +32.9% | 960,000 | +12.9% | 1.16% | +20.4% |
| HZNP | HORIZON THERAPEUTICS PUB L | $58,525,000 | +1.7% | 625,000 | 0.0% | 1.16% | -7.8% | |
| VERV | New | VERVE THERAPEUTICS INC | $58,011,000 | – | 962,826 | +100.0% | 1.15% | – |
| EAR | Buy | EARGO INC | $57,870,000 | +36.0% | 1,450,000 | +70.3% | 1.14% | +23.3% |
| TFX | TELEFLEX INCORPORATED | $52,233,000 | -3.3% | 130,000 | 0.0% | 1.03% | -12.4% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $51,542,000 | -7.0% | 319,085 | -1.4% | 1.02% | -15.8% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $50,856,000 | +20.1% | 300,000 | 0.0% | 1.00% | +8.8% | |
| PRTA | Sell | PROTHENA CORP PLC | $48,844,000 | +68.1% | 950,091 | -17.9% | 0.96% | +52.2% |
| ARVN | Buy | ARVINAS INC | $48,210,000 | +17.3% | 626,100 | +0.7% | 0.95% | +6.2% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $44,338,000 | -13.5% | 465,000 | +3.3% | 0.88% | -21.6% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $44,071,000 | -0.6% | 386,618 | +4.8% | 0.87% | -9.9% |
| ACHC | ACADIA HEALTHCARE COMPANY IN | $43,925,000 | +9.8% | 700,000 | 0.0% | 0.87% | -0.6% | |
| HCAT | HEALTH CATALYST INC | $43,575,000 | +18.7% | 785,000 | 0.0% | 0.86% | +7.5% | |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $41,790,000 | – | 1,500,000 | +100.0% | 0.83% | – |
| SWAV | SHOCKWAVE MED INC | $41,741,000 | +45.7% | 220,000 | 0.0% | 0.82% | +32.0% | |
| BHG | New | BRIGHT HEALTH GROUP INC | $40,755,000 | – | 2,375,000 | +100.0% | 0.80% | – |
| PEN | PENUMBRA INC | $40,424,000 | +1.3% | 147,500 | 0.0% | 0.80% | -8.3% | |
| ARDX | Buy | ARDELYX INC | $39,786,000 | +16.1% | 5,248,829 | +1.4% | 0.79% | +5.1% |
| SGEN | SEAGEN INC | $39,470,000 | +13.7% | 250,000 | 0.0% | 0.78% | +3.0% | |
| BIIB | BIOGEN INC | $39,302,000 | +23.8% | 113,500 | 0.0% | 0.78% | +12.1% | |
| CVET | Buy | COVETRUS INC | $39,285,000 | -6.4% | 1,455,000 | +3.9% | 0.78% | -15.2% |
| EHC | ENCOMPASS HEALTH CORP | $39,015,000 | -4.7% | 500,000 | 0.0% | 0.77% | -13.7% | |
| NVCR | NOVOCURE LTD | $38,819,000 | +67.8% | 175,000 | 0.0% | 0.77% | +51.9% | |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $38,643,000 | -13.9% | 2,845,618 | +2.5% | 0.76% | -22.0% |
| ACCD | Buy | ACCOLADE INC | $36,116,000 | +27.4% | 665,000 | +6.4% | 0.71% | +15.3% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $35,884,000 | +22.9% | 1,699,043 | +17.6% | 0.71% | +11.3% |
| BSX | BOSTON SCIENTIFIC CORP | $34,208,000 | +10.6% | 800,000 | 0.0% | 0.68% | +0.1% | |
| PPD | PPD INC | $31,111,000 | +21.8% | 675,000 | 0.0% | 0.62% | +10.4% | |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $30,717,000 | +2.1% | 233,500 | 0.0% | 0.61% | -7.6% | |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $30,387,000 | +25.8% | 626,527 | +0.8% | 0.60% | +14.0% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $29,725,000 | -50.5% | 448,000 | +3.6% | 0.59% | -55.2% |
| CGEM | CULLINAN ONCOLOGY INC | $27,705,000 | -38.2% | 1,075,912 | 0.0% | 0.55% | -44.0% | |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $26,559,000 | +1.5% | 650,000 | 0.0% | 0.52% | -8.1% | |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $26,345,000 | -11.5% | 1,523,723 | +1.4% | 0.52% | -19.8% |
| LUNG | PULMONX CORP | $26,141,000 | -3.5% | 592,500 | 0.0% | 0.52% | -12.5% | |
| ALLK | ALLAKOS INC | $26,098,000 | -25.6% | 305,706 | 0.0% | 0.52% | -32.6% | |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $26,054,000 | +88.8% | 1,016,945 | +1.2% | 0.52% | +71.1% |
| SRPT | SAREPTA THERAPEUTICS INC | $25,557,000 | +4.3% | 328,750 | 0.0% | 0.50% | -5.6% | |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $25,570,000 | -15.4% | 262,500 | +1.5% | 0.50% | -23.5% |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $25,034,000 | -51.2% | 1,619,248 | +3.8% | 0.50% | -55.8% |
| EPZM | Buy | EPIZYME INC | $25,025,000 | +2.5% | 3,011,487 | +7.4% | 0.50% | -7.1% |
| GH | GUARDANT HEALTH INC | $24,838,000 | -18.6% | 200,000 | 0.0% | 0.49% | -26.3% | |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $24,390,000 | -12.2% | 1,000,000 | -7.1% | 0.48% | -20.5% |
| CNMD | Buy | CONMED CORP | $22,332,000 | +101.0% | 162,500 | +91.0% | 0.44% | +82.2% |
| OSH | OAK STR HEALTH INC | $21,964,000 | +7.9% | 375,000 | 0.0% | 0.43% | -2.3% | |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $21,800,000 | -40.8% | 1,494,164 | +1.3% | 0.43% | -46.4% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $21,749,000 | -0.3% | 920,000 | 0.0% | 0.43% | -9.7% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $21,152,000 | +10.5% | 253,500 | 0.0% | 0.42% | 0.0% | |
| ABCM | Buy | ABCAM PLCads | $20,896,000 | +1.7% | 1,097,500 | +2.6% | 0.41% | -7.8% |
| XENT | Buy | INTERSECT ENT INC | $20,850,000 | -7.6% | 1,220,000 | +12.9% | 0.41% | -16.3% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $20,636,000 | +27.2% | 4,754,900 | +0.3% | 0.41% | +15.3% |
| SRRA | Buy | SIERRA ONCOLOGY INC | $19,833,000 | +13.1% | 1,018,658 | +0.1% | 0.39% | +2.6% |
| DXCM | Buy | DEXCOM INC | $19,471,000 | +261.2% | 45,600 | +204.0% | 0.38% | +226.3% |
| INNV | Buy | INNOVAGE HLDG CORP | $19,232,000 | +57.0% | 902,500 | +90.0% | 0.38% | +42.3% |
| TBIO | Buy | TRANSLATE BIO INC | $19,093,000 | +78.2% | 693,266 | +6.7% | 0.38% | +61.1% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $18,922,000 | -27.4% | 4,320,000 | +3.0% | 0.37% | -34.2% |
| BMEA | New | BIOMEA FUSION INC | $18,194,000 | – | 1,165,582 | +100.0% | 0.36% | – |
| SPRB | Buy | SPRUCE BIOSCIENCES INC | $17,992,000 | -31.4% | 1,605,001 | +1.6% | 0.36% | -37.8% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $17,861,000 | -0.1% | 403,270 | +0.0% | 0.35% | -9.5% |
| KURA | Buy | KURA ONCOLOGY INC | $17,030,000 | -15.2% | 816,800 | +15.0% | 0.34% | -23.1% |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $16,994,000 | -83.8% | 791,133 | -53.3% | 0.34% | -85.3% |
| CYTOKINETICS INCnote 4.000%11/1 | $16,570,000 | -13.2% | 8,000,000 | 0.0% | 0.33% | -21.6% | ||
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $16,547,000 | +1.5% | 1,679,921 | +1.3% | 0.33% | -8.1% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $16,475,000 | +89.0% | 450,258 | +78.6% | 0.33% | +71.6% |
| NKTX | Buy | NKARTA INC | $15,780,000 | -2.5% | 497,948 | +1.2% | 0.31% | -11.6% |
| CHMA | Buy | CHIASMA INC | $15,411,000 | +126.4% | 3,258,144 | +49.8% | 0.30% | +106.1% |
| OLK | Buy | OLINK HLDG ABsponsored ads | $14,629,000 | +1.6% | 425,000 | +6.2% | 0.29% | -8.0% |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $14,640,000 | +39.5% | 596,096 | +3.7% | 0.29% | +26.2% |
| APLT | APPLIED THERAPEUTICS INC | $14,581,000 | +10.8% | 701,680 | 0.0% | 0.29% | +0.3% | |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $14,401,000 | -4.9% | 4,542,769 | +1.1% | 0.28% | -13.6% |
| EPIX | ESSA PHARMA INC | $14,372,000 | -1.6% | 503,035 | 0.0% | 0.28% | -11.0% | |
| INZY | Buy | INOZYME PHARMA INC | $14,318,000 | -12.7% | 840,272 | +1.5% | 0.28% | -20.9% |
| ANAB | ANAPTYSBIO INC | $13,879,000 | +20.3% | 535,232 | 0.0% | 0.27% | +8.7% | |
| GMDA | Buy | GAMIDA CELL LTD | $13,506,000 | -20.5% | 2,107,000 | +0.3% | 0.27% | -28.0% |
| SPRO | SPERO THERAPEUTICS INC | $13,484,000 | -5.2% | 965,928 | 0.0% | 0.27% | -14.2% | |
| AKRO | Buy | AKERO THERAPEUTICS INC | $13,115,000 | -13.3% | 528,601 | +1.4% | 0.26% | -21.5% |
| LEGN | LEGEND BIOTECH CORPsponsored ads | $12,833,000 | +41.5% | 312,618 | 0.0% | 0.25% | +28.3% | |
| GOSSAMER BIO INCnote 5.000% 6/0 | $12,585,000 | -10.0% | 15,573,000 | 0.0% | 0.25% | -18.4% | ||
| MGNX | Buy | MACROGENICS INC | $12,243,000 | -2.3% | 455,816 | +15.8% | 0.24% | -11.4% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $11,871,000 | -6.9% | 606,280 | +1.2% | 0.24% | -15.5% |
| GLPG | GALAPAGOS NVspon adr | $11,367,000 | -10.6% | 165,000 | 0.0% | 0.22% | -19.1% | |
| PRTK | Sell | PARATEK PHARMACEUTICALS INC | $11,285,000 | -5.1% | 1,654,714 | -1.8% | 0.22% | -13.9% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $10,978,000 | -12.1% | 1,577,296 | 0.0% | 0.22% | -20.5% | |
| PRLD | Buy | PRELUDE THERAPEUTICS INC | $10,947,000 | -33.2% | 382,359 | +1.1% | 0.22% | -39.7% |
| XENE | XENON PHARMACEUTICALS INC | $10,660,000 | +4.0% | 572,500 | 0.0% | 0.21% | -5.8% | |
| RPHM | New | RENEO PHARMACEUTICALS INC | $10,534,000 | – | 1,129,024 | +100.0% | 0.21% | – |
| CGEN | Buy | COMPUGEN LTDord | $10,242,000 | -2.2% | 1,236,988 | +1.4% | 0.20% | -11.8% |
| WST | WEST PHARMACEUTICAL SVSC INC | $10,234,000 | +27.4% | 28,500 | 0.0% | 0.20% | +15.4% | |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $10,184,000 | +0.3% | 785,769 | +0.5% | 0.20% | -9.0% |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $9,979,000 | – | 157,900 | +100.0% | 0.20% | – |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $9,983,000 | -28.3% | 687,500 | +0.7% | 0.20% | -35.2% |
| OHPAU | ORION ACQUISITION CORPunit 02/19/2026 | $9,920,000 | -0.8% | 1,000,000 | 0.0% | 0.20% | -10.1% | |
| FOLD | AMICUS THERAPEUTICS INC | $9,761,000 | -2.4% | 1,012,506 | 0.0% | 0.19% | -11.5% | |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $9,636,000 | -7.9% | 682,449 | +1.4% | 0.19% | -16.7% |
| STTK | Sell | SHATTUCK LABS INC | $9,088,000 | -20.0% | 313,499 | -19.3% | 0.18% | -27.4% |
| FSTX | New | F-STAR THERAPEUTICS INC | $9,056,000 | – | 1,054,232 | +100.0% | 0.18% | – |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $8,510,000 | – | 373,739 | +100.0% | 0.17% | – |
| NRIX | Buy | NURIX THERAPEUTICS INC | $8,366,000 | -13.5% | 315,350 | +1.4% | 0.16% | -21.8% |
| FGEN | FIBROGEN INC | $8,327,000 | -23.3% | 312,687 | 0.0% | 0.16% | -30.4% | |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $8,355,000 | +54.0% | 247,200 | +6.6% | 0.16% | +39.8% |
| KNTE | Buy | KINNATE BIOPHARMA INC | $7,719,000 | -24.1% | 331,586 | +1.6% | 0.15% | -31.1% |
| ATHA | Sell | ATHIRA PHARMA INC | $7,662,000 | -47.2% | 748,202 | -5.1% | 0.15% | -52.2% |
| FUSN | FUSION PHARMACEUTICALS INC | $7,662,000 | -24.6% | 948,327 | 0.0% | 0.15% | -32.0% | |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $6,859,000 | +27.6% | 1,843,764 | +18.6% | 0.14% | +16.2% |
| TARA | Buy | PROTARA THERAPEUTICS INC | $6,755,000 | -37.8% | 693,542 | +0.5% | 0.13% | -43.5% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $6,604,000 | -32.5% | 332,050 | +1.5% | 0.13% | -38.5% |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $6,582,000 | -19.8% | 1,545,000 | 0.0% | 0.13% | -27.4% | |
| Buy | TRILLIUM THERAPEUTICS INC | $6,096,000 | -8.6% | 628,500 | +1.2% | 0.12% | -17.2% | |
| FATE | FATE THERAPEUTICS INC | $6,075,000 | +5.2% | 70,000 | 0.0% | 0.12% | -4.8% | |
| ATAI | New | ATAI LIFE SCIENCES NV | $5,828,000 | – | 315,028 | +100.0% | 0.12% | – |
| GRTX | GALERA THERAPEUTICS INC | $5,586,000 | +11.5% | 568,252 | 0.0% | 0.11% | +0.9% | |
| EDAP | New | EDAP TMS S Asponsored adr | $5,395,000 | – | 760,900 | +100.0% | 0.11% | – |
| ACRX | Buy | ACELRX PHARMACEUTICALS INC | $5,228,000 | -18.8% | 3,788,757 | +0.1% | 0.10% | -26.4% |
| BCEL | Buy | ATRECA INC | $3,918,000 | -43.7% | 459,830 | +1.3% | 0.08% | -49.3% |
| TPST | New | TEMPEST THERAPEUTICS INC | $3,468,000 | – | 310,161 | +100.0% | 0.07% | – |
| BLSA | BCLS ACQUISITION CORP | $3,254,000 | -0.4% | 309,000 | 0.0% | 0.06% | -9.9% | |
| PSTX | POSEIDA THERAPEUTICS INC | $2,903,000 | +4.9% | 289,754 | 0.0% | 0.06% | -5.0% | |
| RETROPHIN INCnote 2.500% 9/1 | $2,765,000 | -17.7% | 3,250,000 | 0.0% | 0.06% | -24.7% | ||
| NUVB | Sell | NUVATION BIO INC | $2,248,000 | -46.5% | 241,485 | -39.9% | 0.04% | -52.2% |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $2,101,000 | +1.8% | 206,000 | 0.0% | 0.04% | -6.7% | |
| TMPMU | TURMERIC ACQUISITION CORPunit 10/08/2025 | $2,072,000 | +0.6% | 206,000 | 0.0% | 0.04% | -8.9% | |
| FSII | FS DEVELOPMENT CORP II | $2,089,000 | +0.2% | 209,332 | 0.0% | 0.04% | -8.9% | |
| JYAC | JIYA ACQUISITION CORP | $2,050,000 | +1.0% | 206,200 | 0.0% | 0.04% | -6.8% | |
| PHICU | POPULATION HEALTH INVS CO INunit 99/99/9999 | $2,041,000 | +1.0% | 201,044 | 0.0% | 0.04% | -9.1% | |
| HLXA | HELIX ACQUISITION CORP | $1,599,000 | +1.5% | 154,500 | 0.0% | 0.03% | -5.9% | |
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,393,000 | -0.6% | 1,500,000 | 0.0% | 0.03% | -9.7% | ||
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,429,000 | -6.4% | 1,500,000 | 0.0% | 0.03% | -15.2% | ||
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,347,000 | -0.5% | 1,000,000 | 0.0% | 0.03% | -10.0% | ||
| PACIRA BIOSCIENCES INCnote 2.375% 4/0 | $1,094,000 | -9.7% | 1,000,000 | 0.0% | 0.02% | -15.4% | ||
| NEVRO CORPnote 2.750% 4/0 | $866,000 | +12.3% | 500,000 | 0.0% | 0.02% | 0.0% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $348,000 | -2.8% | 134,028 | 0.0% | 0.01% | -12.5% | |
| ARPO | New | AERPIO PHARMACEUTICALS INC | $225,000 | – | 133,375 | +100.0% | 0.00% | – |
| LSAQ | Exit | LIFESCI ACQUISITION II CORP | $0 | – | -206,200 | -100.0% | -0.05% | – |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -119,114 | -100.0% | -0.05% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -80,000 | -100.0% | -0.08% | – |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -364,800 | -100.0% | -0.23% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -140,000 | -100.0% | -0.26% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -266,520 | -100.0% | -0.28% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -100,000 | -100.0% | -0.45% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -650,000 | -100.0% | -0.70% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -2,660,822 | -100.0% | -2.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.